A pancreatic cancer therapy that utilizes injections of antibodies can double the survival rate of patients and represents a breakthrough in treating the disease, researchers announced yesterday in Taipei.
Lee Wen-hwa (李文華), chancellor of the China Medical University in Taichung and an Academia Sinica research fellow, told a news conference in Taipei that his team discovered that the cancer cells trigger the over-expression of the IL17RB receptor, a protein in the plasma membrane of surface pancreatic cancer cells that receives chemical signals.
The phenomenon is also seen in breast cancer cells, and his team had success in using the antibody to treat breast cancer.
“From our previous research, we knew that the over-expression of the IL17RB receptor positively correlates with conditions or breast cancer — the higher the level of over-expression, the worse the breast cancer becomes,” Lee said.
Hoping to replicate the success they had in treating breast cancer, the research team used the antibody targeting IL17RB on mice whose pancreases had been implanted with cancer cells and found that the survival rate of the mice doubled, from an average of 60 days to 120 days.
The antibody severs the intercellular pathway between IL17RB and chemokine, a protein secreted by cells that plays a key role in metastasis, thereby curbing the transfer of cancer cells, Lee said.
“When we cut the mice open, their lungs and livers were completely free from pancreatic cancer cells, indicating that the metastasis had been suppressed,” he said.
In addition, since IL17RB plays an insignificant role in other parts of the human body, targeting this receptor with an antibody causes minimal side effects, he said.
The findings also provide hope of treating other types of cancer that cause the over-expression of IL17RB, such as bladder cancer, oral cancer and some brain tumors, Lee said.
Pancreatic cancer is the 13th- most common cancer in the nation and is usually considered incurable, he said.
Because pancreatic cancer cells can move to other organs, operating on patients is very difficult and existing chemotherapy treatments can only extend a patient’s life by three to six months, he said.
More than 70 percent of people with pancreatic cancer die less than one year after diagnosis and about 90 percent of them die within five years, he said.
Lee said the antibody must be moderated for use on humans, which will take one to two years, and it must undergo clinical trials.
“Once it passes the clinical tests, it will enter mass production. We hope that it will become available for clinical use in five years,” he said.
A provisional patent application for the antibody was filed last year and the assessment of the patent will begin in June, Lee said.
A paper on the team’s research findings was submitted to the Journal of Experimental Medicine in September last year and was published on Tuesday last week.
SEND A MESSAGE: Sinking the amphibious assault ship, the lead warship of its class, is meant to show China the US Navy is capable of sinking their ships, an analyst said The US and allied navies plan to sink a 40,000-tonne ship at the latest Rim of the Pacific (RIMPAC) exercise to simulate defeating a Chinese amphibious assault on Taiwan. This year’s RIMPAC — the 29th iteration of the world’s largest naval exercise — involves the US, 28 partners, more than 25,000 personnel, 40 warships, three submarines and more than 150 aircraft operating in and around Hawaii from yesterday to Aug. 1, the US Navy said in a press release. The major components of the event include multidomain warfare exercises in multiship surface engagements, anti-submarine warfare and multi-axis defense of a carrier strike
Taiwanese could risk being extradited to China when traveling in countries with close ties to Beijing, Taiwan Association of University Professors deputy chairman Chen Li-fu (陳俐甫) said on Friday. Chen’s comments came after China on Friday last week announced new judicial guidelines targeting Taiwanese independence advocates. Myanmar, Cambodia, Laos and Djibouti are among the countries where Taiwanese could risk being extradited to China, he said. The Mainland Affairs Council (MAC) on Thursday elevated the travel alert for China, Hong Kong and Macau to “orange” after Beijing announced its guidelines to “severely punish Taiwanese independence diehards for splitting the country and inciting secession.” Extradition treaties
The airspace around Taiwan Taoyuan International Airport and Taipei International Airport (Songshan airport) is to be closed for an hour on July 25 and July 23 respectively, due to the Han Kuang military exercises, the Ministry of National Defense said yesterday. The annual exercise is to be held on Taiwan proper and its outlying islands from July 22 to 26. During last year’s exercise, the military conducted anti-aircraft landing drills at the Taoyuan airport for the first time, for which a one-hour no-fly ban was issued. Based on a live-fire bulletin sent out by the Maritime and Port Bureau, the nation’s
Taiwan and Thailand have signed an agreement to promote and protect bilateral investment and trade, the Executive Yuan’s Office of Trade Negotiations (OTN) said on Friday. The agreement on “Promotion and Protection of Investments” was signed by Representative to Thailand Chang Chun-fu (張俊福) and Thailand Trade and Economic Office in Taipei executive director Narong Boonsatheanwong on Thursday, the OTN said in a news release. Thailand has become the fifth trading partner to sign an investment agreement with Taiwan since 2016, following earlier agreements with the Philippines, India, Vietnam and Canada, the OTN said. The deal marks a significant milestone in the development of